Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Meeraus W, Joy M, Ouwens M, Taylor KS, Venkatesan S, Dennis J, Tran TN, Dashtban A, Fan X, Williams R, Morris T, Carty L, Kar D, Hoang U, Feher M, Forbes A, Jamie G, Hinton W, Sanecka K, Byford R, Anand SN, Hobbs FDR, Clifton DA, Pollard AJ, Taylor S, de Lusignan S. Meeraus W, et al. Among authors: venkatesan s. J Infect. 2024 Apr;88(4):106129. doi: 10.1016/j.jinf.2024.106129. Epub 2024 Feb 29. J Infect. 2024. PMID: 38431156 Free article.
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].
Evans RA, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E, Bell S, Carty L, Evans K, Graham S, Justo N, Moss P, Venkatesan S, Yokota R, Ferreira C, McNulty R, Taylor S, Quint JK. Evans RA, et al. Among authors: venkatesan s. Lancet Reg Health Eur. 2024 Jul 25;44:101008. doi: 10.1016/j.lanepe.2024.101008. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39155983 Free PMC article.
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.
Evans RA, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E, Bell S, Carty L, Evans K, Graham S, Justo N, Moss P, Venkatesan S, Yokota R, Ferreira C, McNulty R, Taylor S, Quint JK. Evans RA, et al. Among authors: venkatesan s. Lancet Reg Health Eur. 2023 Oct 13;35:100747. doi: 10.1016/j.lanepe.2023.100747. eCollection 2023 Dec. Lancet Reg Health Eur. 2023. PMID: 38115964 Free PMC article.
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period.
Hayek S, Levy J, Shaham G, Dagan N, Serby D, Duskin-Bitan H, Dube S, Ferreira C, Livnat I, Talarico C, Taylor S, Venkatesan S, Yarden A, Balicer RD, Netzer D, Peretz A. Hayek S, et al. Among authors: venkatesan s. Infect Dis Ther. 2025 Jan 7. doi: 10.1007/s40121-024-01100-3. Online ahead of print. Infect Dis Ther. 2025. PMID: 39762664
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling.
Lu WT, Zalmas LP, Bailey C, Black JRM, Martinez-Ruiz C, Pich O, Gimeno-Valiente F, Usaite I, Magness A, Thol K, Webber TA, Jiang M, Saunders RE, Liu YH, Biswas D, Ige EO, Aerne B, Grönroos E, Venkatesan S, Stavrou G, Karasaki T, Al Bakir M, Renshaw M, Xu H, Schneider-Luftman D, Sharma N, Tovini L; TRACERx Consortium; Jamal-Hanjani M, McClelland SE, Litchfield K, Birkbak NJ, Howell M, Tapon N, Fugger K, McGranahan N, Bartek J, Kanu N, Swanton C. Lu WT, et al. Among authors: venkatesan s. Nat Cell Biol. 2024 Dec 30. doi: 10.1038/s41556-024-01558-w. Online ahead of print. Nat Cell Biol. 2024. PMID: 39738653
577 results